Jonathan S. Berek

31.4k total citations · 10 hit papers
297 papers, 16.6k citations indexed

About

Jonathan S. Berek is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Jonathan S. Berek has authored 297 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Reproductive Medicine, 92 papers in Obstetrics and Gynecology and 88 papers in Oncology. Recurrent topics in Jonathan S. Berek's work include Ovarian cancer diagnosis and treatment (146 papers), Endometrial and Cervical Cancer Treatments (73 papers) and Cervical Cancer and HPV Research (34 papers). Jonathan S. Berek is often cited by papers focused on Ovarian cancer diagnosis and treatment (146 papers), Endometrial and Cervical Cancer Treatments (73 papers) and Cervical Cancer and HPV Research (34 papers). Jonathan S. Berek collaborates with scholars based in United States, United Kingdom and Germany. Jonathan S. Berek's co-authors include Neville F. Hacker, William H. Parker, Bradley J. Monk, Sean Kehoe, Michael Friedländer, David S. Alberts, William A. Peters, Richard J. Stock, William Gordon and Rolland J. Barrett and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

Jonathan S. Berek

293 papers receiving 16.1k citations

Hit Papers

Concurrent Chemotherapy a... 1994 2026 2004 2015 2000 2019 1994 2009 2023 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jonathan S. Berek 8.1k 7.4k 4.7k 4.3k 3.2k 297 16.6k
Pierluigi Benedetti Panici 6.6k 0.8× 6.7k 0.9× 3.9k 0.8× 3.6k 0.8× 2.2k 0.7× 566 16.0k
David G. Mutch 6.9k 0.9× 9.4k 1.3× 4.6k 1.0× 4.3k 1.0× 3.3k 1.0× 449 19.1k
Thomas J. Herzog 6.2k 0.8× 6.1k 0.8× 3.3k 0.7× 3.2k 0.7× 1.7k 0.5× 334 13.3k
Henry C Kitchener 4.9k 0.6× 5.1k 0.7× 3.8k 0.8× 4.0k 0.9× 7.1k 2.2× 235 16.2k
William T. Creasman 8.3k 1.0× 10.9k 1.5× 3.8k 0.8× 2.9k 0.7× 3.8k 1.2× 243 17.4k
John K. Chan 5.1k 0.6× 3.7k 0.5× 2.9k 0.6× 4.1k 0.9× 1.6k 0.5× 277 11.9k
Neville F. Hacker 4.4k 0.5× 3.9k 0.5× 3.8k 0.8× 2.6k 0.6× 2.7k 0.8× 246 11.4k
Frédéric Amant 9.0k 1.1× 8.7k 1.2× 3.5k 0.7× 7.2k 1.7× 2.3k 0.7× 554 21.9k
Robert A. Burger 9.1k 1.1× 3.7k 0.5× 4.4k 0.9× 4.6k 1.1× 1.0k 0.3× 202 14.8k
Bradley J. Monk 9.3k 1.2× 8.1k 1.1× 6.2k 1.3× 8.6k 2.0× 4.9k 1.5× 615 23.2k

Countries citing papers authored by Jonathan S. Berek

Since Specialization
Citations

This map shows the geographic impact of Jonathan S. Berek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Berek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Berek more than expected).

Fields of papers citing papers by Jonathan S. Berek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Berek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Berek. The network helps show where Jonathan S. Berek may publish in the future.

Co-authorship network of co-authors of Jonathan S. Berek

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Berek. A scholar is included among the top collaborators of Jonathan S. Berek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Berek. Jonathan S. Berek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peters, William A., Pengfei Liu, Rolland J. Barrett, et al.. (2023). Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix. Journal of Clinical Oncology. 41(29). 4605–4612. 13 indexed citations
2.
Wang, Huaijun, Ahmed El Kaffas, Terry S. Desser, et al.. (2023). In Vivo Ultrasound Molecular Imaging in the Evaluation of Complex Ovarian Masses: A Practical Guide to Correlation with Ex Vivo Immunohistochemistry. Advanced Biology. 7(8). e2300091–e2300091. 1 indexed citations
3.
Berek, Jonathan S., Xavier Matías‐Guiu, Carien L. Creutzberg, et al.. (2023). FIGO staging of endometrial cancer: 2023. Journal of Gynecologic Oncology. 34(5). e85–e85. 112 indexed citations breakdown →
4.
Andersen, Barbara L., Christina Lacchetti, Kimlin Ashing, et al.. (2023). Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 41(18). 3426–3453. 105 indexed citations breakdown →
5.
Benedict, Catherine, Erqi L. Pollom, Lidia Schapira, et al.. (2022). Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors. Seminars in Oncology Nursing. 38(6). 151316–151316. 5 indexed citations
6.
Mirza, Mansoor Raza, Gabriel Lindahl, Sven Mahner, et al.. (2022). Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. Cancer Research Communications. 2(11). 1436–1444. 5 indexed citations
7.
Benedict, Catherine, Sean R. Zion, Allison W. Kurian, et al.. (2022). Association of illness mindsets with health-related quality of life in cancer survivors.. Health Psychology. 41(6). 389–395. 12 indexed citations
8.
Kurian, Allison W., Kevin C. Ward, Paul Abrahamse, et al.. (2021). Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019. Journal of Clinical Oncology. 39(15). 1631–1640. 74 indexed citations
9.
Kurian, Allison W., Paul Abrahamse, Irina Bondarenko, et al.. (2021). Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer. JNCI Journal of the National Cancer Institute. 114(2). 245–253. 9 indexed citations
10.
Benedict, Catherine, Lidia Schapira, Tara M. Sullivan, et al.. (2021). Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors. Psycho-Oncology. 31(1). 9–20. 62 indexed citations
11.
Kurian, Allison W., Paul Abrahamse, Kevin C. Ward, et al.. (2021). Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes. JCO Precision Oncology. 5(5). 1853–1859. 5 indexed citations
12.
Bhatla, Neerja, Jonathan S. Berek, Mauricio Cuello Fredes, et al.. (2019). Revised FIGO staging for carcinoma of the cervix uteri. International Journal of Gynecology & Obstetrics. 145(1). 129–135. 636 indexed citations breakdown →
13.
Berek, Jonathan S., Koji Matsuo, Brendan H. Grubbs, et al.. (2019). Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. Journal of Gynecologic Oncology. 30(2). e40–e40. 32 indexed citations
14.
Lum, Deirdre, Eric R. Sokol, Jonathan S. Berek, et al.. (2016). Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation. Journal of Minimally Invasive Gynecology. 23(4). 548–556. 39 indexed citations
15.
Simpkins, Fiona, Aurea E. Flores, Christina Chu, et al.. (2013). Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study. Cancer Immunology Research. 1(3). 168–178. 41 indexed citations
16.
Berek, Jonathan S., Eva Chalas, Mitchell I. Edelson, et al.. (2010). Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy. Obstetrics and Gynecology. 116(3). 733–743. 69 indexed citations
17.
Parker, William H., Michael S. Broder, Eunice Chang, et al.. (2009). Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study. Obstetrics and Gynecology. 113(5). 1027–1037. 454 indexed citations breakdown →
18.
Chan, John K. & Jonathan S. Berek. (2007). Impact of the Human Papilloma Vaccine on Cervical Cancer. Journal of Clinical Oncology. 25(20). 2975–2982. 42 indexed citations
19.
Peters, William A., Rolland J. Barrett, Richard J. Stock, et al.. (2000). Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix. Journal of Clinical Oncology. 18(8). 1606–1613. 1736 indexed citations breakdown →
20.
Niloff, Jonathan M., Robert C. Knapp, Philip T. Lavin, et al.. (1986). The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. American Journal of Obstetrics and Gynecology. 155(1). 56–60. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026